Takeda Pharmaceutical (TAK) Non-Current Assets (2017 - 2026)
Takeda Pharmaceutical (TAK) reported Non-Current Assets of $78.51 billion for the quarter ended Jun 30, 2026, down 1.1% from $79.42 billion a year earlier and down 0.9% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Non-Current Assets (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical posted Non-Current Assets of $82.52 billion, up 7.2% from the prior year.
- Non-Current Assets has a five-year compound annual growth rate of -3.0% (years ended Mar 2021 to Mar 2026).
- By year, Non-Current Assets came in at $76.99 billion in the year ended Mar 31, 2025 (-11.5%), $87.02 billion in the year ended Mar 31, 2024 (+1.7%), $85.57 billion in the year ended Mar 31, 2023 (-9.2%) and $94.27 billion in the year ended Mar 31, 2022 (-2.0%).
- Five-year quarterly Non-Current Assets spans a low of $76.87 billion in the quarter ended Mar 31, 2025 and a high of $91.08 billion in the quarter ended Mar 31, 2022.
- Year over year, Non-Current Assets gained in three of the last eight quarters, with an average decline of 2.7%.
- The high point for year-over-year Non-Current Assets in five years was the quarter ended Dec 31, 2023 (growth of 3.3%); the low point was the quarter ended Sep 30, 2024 (a decline of 10.1%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $79.2 billion (quarter ended Mar 31, 2026), $79.87 billion (quarter ended Dec 31, 2025) and $78.38 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 78.51 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.51 Bn |
| Mar 31, 2026 | 79.20 Bn |
| Dec 31, 2025 | 79.87 Bn |
| Sep 30, 2025 | 78.38 Bn |
| Jun 30, 2025 | 79.42 Bn |
| Mar 31, 2025 | 76.87 Bn |
| Dec 31, 2024 | 81.25 Bn |
| Sep 30, 2024 | 77.22 Bn |
| Jun 30, 2024 | 84.28 Bn |
| Mar 31, 2024 | 84.69 Bn |
| Dec 31, 2023 | 79.79 Bn |
| Sep 30, 2023 | 85.93 Bn |
| Jun 30, 2023 | 89.90 Bn |
| Mar 31, 2023 | 87.39 Bn |
| Dec 31, 2022 | 77.22 Bn |
| Sep 30, 2022 | 85.75 Bn |
| Jun 30, 2022 | 89.05 Bn |
| Mar 31, 2022 | 91.08 Bn |
| Jun 30, 2021 | 93.00 Bn |
| Mar 31, 2021 | 96.36 Bn |
API Access
Takeda Pharmaceutical Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();